Arrowstreet Capital’s US Physical Therapy USPH Stock Holding History

Arrowstreet Capital’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,939	Closed	-$1.65M	–	1746
2021 Q3	$1.65M	Sell	14,939 -4,600	-24%	-$524K	﹤0.01%	1177
2021 Q2	$2.26M	Buy	19,539 +1,800	+10%	+$207K	﹤0.01%	1311
2021 Q1	$1.85M	Sell	17,739 -4,965	-22%	-$617K	﹤0.01%	1587
2020 Q4	$2.73M	Buy	22,704 +3,979	+21%	+$401K	﹤0.01%	1482
2020 Q3	$1.63M	Buy	+18,725	New	+$1.61M	﹤0.01%	1647
2018 Q4	–	Sell	-9,250	Closed	-$1.1M	–	1518
2018 Q3	$1.1M	Buy	9,250 +1,950	+27%	+$220K	﹤0.01%	780
2018 Q2	$701K	Buy	+7,300	New	+$677K	﹤0.01%	861
2016 Q4	–	Sell	-4,300	Closed	-$270K	–	2513
2016 Q3	$270K	Buy	+4,300	New	+$265K	﹤0.01%	1371
2015 Q3	–	Sell	-13,804	Closed	-$756K	–	1504
2015 Q2	$756K	Sell	13,804 -6,303	-31%	-$312K	﹤0.01%	895
2015 Q1	$955K	Sell	20,107 -6,006	-23%	-$255K	0.01%	726
2014 Q4	$1.1M	Sell	26,113 -1,082	-4%	-$42.6K	0.01%	881
2014 Q3	$962K	Hold	27,195	–	–	0.01%	736
2014 Q2	$930K	Buy	27,195 +15,103	+125%	+$487K	﹤0.01%	728
2014 Q1	$418K	Buy	+12,092	New	+$401K	﹤0.01%	991

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital's USPH Position: Q4 2021 in Review

Arrowstreet Capital sold out of US Physical Therapy (USPH) in Q4 2021, closing a stake of 14,939 shares — an estimated $1.65M sold.

Arrowstreet Capital first reported a position in USPH in Q1 2014 and held it in 14 quarters. The position peaked at $2.73M in Q4 2020. 210 funds tracked by Wall St. Rank hold USPH as of Q4 2021.

Arrowstreet Capital reported no remaining US Physical Therapy position as of Q4 2021 after selling out during the quarter.
Arrowstreet Capital sold 14,939 US Physical Therapy shares in Q4 2021, an estimated $1.65M.
Arrowstreet Capital first reported a position in US Physical Therapy in Q1 2014 and held it in 14 quarters.
Arrowstreet Capital's US Physical Therapy position peaked at $2.73M in Q4 2020.
210 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2021.

Based on Arrowstreet Capital's 13F filing for Q4 2021, filed 14 Feb 2022.